Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center

Aim of this study was to investigate the long-term results of botulinum toxin A (BoNT-A) injections for the treatment of benign essential blepharospasm (BEB) and to report our experience with (ultra-)long-term treatment with onabotulinumtoxin-A. We conducted a retrospective cross-sectional analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wabbels, Bettina, Fimmers, Rolf, Roggenkämper, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875585/
https://www.ncbi.nlm.nih.gov/pubmed/35202148
http://dx.doi.org/10.3390/toxins14020120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875585/
https://www.ncbi.nlm.nih.gov/pubmed/35202148
http://dx.doi.org/10.3390/toxins14020120

Ejemplares similares